Immunoglobulin E-independent major histocompatibility complex- restricted T cell peptide epitope-induced late asthmatic reactions

Journal of Experimental Medicine

Volumn 189, Issue 12, 1999, Pages 1885-1894

  Haselden, Brigitte M ^a   Kay, A Barry ^a   Larché, Mark ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Allergen; Allergy; Fel d 1; Human histocompatibility leukocyte antigen; T lymphocyte

Indexed keywords

ALLERGEN; EPITOPE; HLA ANTIGEN; IMMUNOGLOBULIN E; INTERLEUKIN 5;

ARTICLE; ASTHMA; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS LINKING; CYTOKINE PRODUCTION; FEMALE; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; WHEEZING;

ADULT; ALLERGENS; AMINO ACID SEQUENCE; ANIMALS; ASTHMA; BASOPHILS; CATS; FEMALE; GLYCOPROTEINS; HISTAMINE; HLA-DR ANTIGENS; HUMANS; IMMUNOGLOBULIN E; INJECTIONS, INTRADERMAL; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; T-LYMPHOCYTES; TUBERCULIN;

EID: 0033591638     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.189.12.1885     Document Type: Article

References (28)

1. Kay, A.B. Concepts of allergy and hypersensitivity. 1997. In Allergy and Allergic Diseases, Vol. 1. A.B. Kay, editor. Blackwell Science, Oxford, UK. 23-35.
2. Azzawi, M., B. Bradley, P.K. Jeffery, A.J. Frew, A.J. Wardlaw, G. Knowles, B. Assoufi, J.V. Collins, S.R. Durham, and A.B. Kay. 1990. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am. Rev. Respir. Dis. 142:1407-1413.
3. Robinson, D.S., Q. Hamid, S. Ying, A. Tsicopoulos, J. Barkans, A.M. Bentley, C. Corrigan, S.R. Durham, and A.B. Kay. 1992. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326: 298-304.
4. Dolovich, J., F.E. Hargreave, R. Chalmers, K.J. Shier, J. Gauldie, and J. Bienenstock. 1973. Late cutaneous allergic responses in isolated IgE-dependent reactions. J. Allergy Clin. Immunol. 52:38-46.
5. Solley, G.O., G.J. Gleich, R.E. Jordon, and A.L. Schroeter. 1976. The late phase of the immediate wheal and flare skin reaction. Its dependence upon IgE antibodies. J. Clin. Invest. 58:408-420.
6. Gaga, M., A.J. Frew, V.A. Varney, and A.B. Kay. 1991. Eosinophil activation and T lymphocyte infiltration in allergen-induced late phase skin reactions and classical delayed-type hypersensitivity. J. Immunol. 147:816-822.
7. Bentley, A.M., Q. Meng, D.S. Robinson, Q. Hamid, A.B. Kay, and S.R. Durham. 1993. Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics. Am. J. Respir. Cell. Mol. Biol. 8:35-42.
8. Corrigan, C.J., and A.B. Kay. 1990. T-lymphocyte activation in acute severe asthma. Relationship to disease severity and atopic status. Am. Rev. Respir. Dis. 141:970-977.
9. + T cells in brown Norway rats. J. Clin. Invest. 96:1303-1310.
10. deSanctis, G.T., A. Itoh, F.H. Green, S. Qin, T. Kimura, J.K. Grobholz, T.R. Martin, T. Maki, and J.M. Drazen. 1997. Lymphocytes regulate genetically determined airway hyperresponsiveness in mice. Nat. Med. 3:460-462.
11. Dickason, R.R., M.M. Huston, D.P. Huston. 1995. Enhanced detection of human IL-5 in biological fluids utilizing murine monoclonal antibodies which delineate distinct neutralizing epitopes. Cytokines. 6:647-656.
12. Corrigan, C.J., and A.B. Kay. 1992. T cells and eosinophils in the pathogenesis of asthma. Immunol. Today. 13:501-507.
13. + T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and non atopic (intrinsic) asthmatics. J. Immunol. 158:3539-3544.
14. Metzger, W.J., D. Zavala, H.B. Richerson, P. Moseley, P. Iwamota, M. Monick, K. Sjoerdsma, and G.W. Hunninghake. 1987. Local allergen challenge and bronchoalveolar lavage of allergic asthmatic lungs. Description of the model and local airway inflammation. Am. Rev. Respir. Dis. 135:433-440.
15. Sihra, B.S., S.R. Durham, S. Walker, O.M. Kon, N.C. Barnes, and A.B. Kay. 1997. Effect of cyclosporin A on the allergen-induced late asthmatic reaction. Thorax. 52:447-452.
16. Kon, O.M., B.S. Sihra, C.H. Compton, T.B. Leonard, A.B. Kay, and N.C. Barnes. 1998. A double blind placebo controlled trial of a chimeric anti CD-4 monoclonal antibody, kleximab (IDEC CE9.1) in chronic severe asthma. Lancet. 352:1109-1113.
17. + T cells precedes the development of tolerance in vivo. Int. Immunol. 8:335-342.
18. Briner, T.J., M.C. Kuo, K.M. Keating, B.L. Rogers, and J.L. Greenstein. 1993. Peripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d 1. Proc. Natl. Acad. Sci. USA. 90:7608-7612.
19. Norman, P.S., J.L. Ohman, Jr., A.A. Long, P.S. Creticos, M.A. Gefter, Z. Shaked, R.A. Wood, P.A. Eggleston, K.B. Hafner, P. Rao, et al. 1996. Treatment of cat allergy with T-cell reactive peptides. Am. J. Respir. Crit. Care Med. 154: 1623-1628.
20. Simons, F.E., M. Imada, Y. Li, W.T. Watson, and K.T. Hay-Glass. 1996. Fel d 1 peptides: effect on skin tests and cytokine synthesis in cat-allergic human subjects. Int. Immunol. 8:1937-1945.
21. Pene, J., A. Desroches, L. Paradis, B. Lebel, M. Farce, C.F. Nicodemus, H. Yssel, and J. Bousquet. 1998. Immunotherapy with Fel d 1 peptides decreases IL-4 release by peripheral blood T cells of patients allergic to cats. J. Allergy Clin. Immunol. 102:571-578.
22. Rogers, B.L., J.F. Bond, S.J. Craig, A.K. Nault, D.B. Segal, J.P. Morgenstern, M.S. Chen, C.B. Bizinkauskas, C.M. Counsell, and A.M. Lussier. 1994. Potential therapeutic recombinant proteins comprised of peptides containing recombined T cell epitopes. Mol. Immunol. 31:955-966.
23. Wardlaw, A.J., R. Moqbel, and A.B. Kay. 1995. Eosinophils: biology and role in disease. Adv. Immunol, 60:151-266.
24. Kuna, P., S.R. Reddigari, T.J. Schall, D. Rucinski, M. Sadick, and A.P. Kaplan. 1993. Characterization of the human basophil response to cytokines, growth factors, and histamine releasing factors of the intercrine/chemokine family. J. Immunol. 150:1932-1943.
25. Santamaria-Babi, L.F., L.J. Picker, M.T. Perez-Soler, K. Drzimalla, P. Flohr, K. Blaser, and C. Hauser. 1995. Circulating allergen-reactive T cells from patients with atopic dermatitis and allergic contact dermatitis express the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen. J. Exp. Med. 181:1935-1940.
26. Zinkemagel, R.M., and P.C. Doherty. 1975. H-2 compatibility requirement for T cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus. Different cytotoxic T cell specificities are associated with structures coded for in H-2K or H-2D J. Exp. Med. 141:1427-1436.
27. Hickling, J.K., C.M. Fenton, K. Howland, S.G. Marsh, and J.B. Rothbard. 1990. Peptides recognized by class I restricted T cells also bind to MHC class II molecules. Int. Immunol. 2:435-441.
28. Valyasevi, M.A., D.E. Maddox, and J.T. Li. 1998. Systemic reactions to skin tests at Mayo Clinic. J. Allergy Clin. Immunol. 101:530. (Abstr.)